Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Apr 1;28(4):404-405.
doi: 10.5551/jat.61747-R. Epub 2021 Jan 23.

Response to "Etiology and Management of Bleeding during ECMO in a COVID-19 Patient"

Masaki Hayakawa  1 , Masanori Matsumoto  1
Affiliations
Comment

Response to "Etiology and Management of Bleeding during ECMO in a COVID-19 Patient"

Masaki Hayakawa et al. J Atheroscler Thromb. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interests.

Comment on

References

    1. Yamada S, Ogawa H and Asakura H: Etiology and management of bleeding during ECMO in a COVID-19 patient. J Atheroscler Thromb, 2021; 28: 402-403 - PMC - PubMed
    1. Hayakawa M, Takano K, Kayashima M, Kasahara K, Fukushima H and Matsumoto M: Management of a COVID-19 Patient during ECMO: Paying Attention to Acquired von Willebrand Syndrome. J Atheroscler Thromb, 2021; 28: 396-401 - PMC - PubMed
    1. Taylor FB, Jr., Toh CH, Hoots WK, Wada H, Levi M and Scientific Subcommittee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost, 2001; 86: 1327-1330 - PubMed
    1. Aoyama T, Ino Y, Ozeki M, Oda M, Sato T, Koshiyama Y, Suzuki S and Fujita M: Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments. Jpn J Pharmacol, 1984; 35: 203-227 - PubMed
    1. Yamamoto M, Kiso M, Sakai-Tagawa Y, Iwatsuki-Horimoto K, Imai M, Takeda M, Kinoshita N, Ohmagari N, Gohda J, Semba K, Matsuda Z, Kawaguchi Y, Kawaoka Y and Inoue JI: The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner. Viruses, 2020; 12: - PMC - PubMed